Josh Silverman exercised options and sold shares under 10b5-1 plan
Rhea-AI Filing Summary
Josh Silverman, CEO and Director of Etsy, Inc. (ETSY), reported multiple transactions on 10/01/2025 under a Rule 10b5-1 plan. He exercised options to acquire 21,666 shares at an exercise price of $10.62 and received 36,406 shares upon restricted stock unit vesting. Concurrently he sold a total of 41,800 shares across several transactions at weighted average prices ranging from about $66.48 to $71.47 (per disclosed ranges). Following these transactions the filing shows various direct and indirect holdings, including 99,080 shares reported in one line and multiple trust-held blocks disclosed. The transactions were made pursuant to a trading plan adopted on 11/05/2024.
Positive
- Option exercise of 21,666 shares at $10.62
- Vesting resulted in 36,406 shares acquired upon RSU settlement
- Transactions executed pursuant to a documented Rule 10b5-1 trading plan adopted on 11/05/2024
Negative
- Reported sales of a total of 41,800 shares on 10/01/2025
- Sales occurred across multiple price ranges with weighted averages reported between $66.48 and $71.47
Insights
Insider used a 10b5-1 plan to exercise options, accept RSU vesting and sell shares totaling 41,800.
The report confirms an option exercise of 21,666 shares at $10.62 and vesting delivery of 36,406 shares, both executed on 10/01/2025. Simultaneous sales of 41,800 shares were executed at weighted average prices disclosed across several ranges.
This activity is recorded under a Rule 10b5-1 trading plan adopted on 11/05/2024, which the filer cites as the basis for the timed transactions; the filing also discloses multiple indirect holdings held in various trusts.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 21,666 | $0.00 | -- |
| Exercise | Restricted Stock Units | 7,189 | $0.00 | -- |
| Exercise | Restricted Stock Units | 8,654 | $0.00 | -- |
| Exercise | Restricted Stock Units | 7,303 | $0.00 | -- |
| Exercise | Restricted Stock Units | 13,260 | $0.00 | -- |
| Exercise | Common Stock | 21,666 | $10.62 | $230K |
| Sale | Common Stock | 342 | $66.98 | $23K |
| Sale | Common Stock | 1,567 | $69.02 | $108K |
| Sale | Common Stock | 13,022 | $70.04 | $912K |
| Sale | Common Stock | 6,735 | $70.90 | $478K |
| Exercise | Common Stock | 36,406 | $0.00 | -- |
| Tax Withholding | Common Stock | 20,134 | $70.49 | $1.42M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.48 to $67.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.48 to $69.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.505 to $70.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.50 to $71.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares of common stock acquired upon the vesting of the restricted stock units. This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units. These shares are held by the JGS 2018 Irrevocable GST Trust (the "GST Trust"). The Reporting Person's spouse is the trustee of the GST Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are held by the JGS 2018 Irrevocable Non-GST Trust (the "Non-GST Trust"). The Reporting Person's spouse is the trustee of the Non-GST Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are held by a grantor retained annuity trust (the "GRAT"). The Reporting Person is the trustee and the beneficiary of the GRAT. These shares are held by the Joshua G. Silverman 2019 Irrevocable Children's Trust (the "2019 Trust"). A family member of the Reporting Person is the trustee of the 2019 Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments. Represents restricted stock units which correspond 1-for-1 with common stock. The restricted stock units vest in 8 equal semi-annual installments, beginning on October 1, 2022, provided the Reporting Person remains continuously employed on each vesting date and has no expiration date. The restricted stock units vest in 8 equal semi-annual installments, beginning on October 1, 2023, provided the Reporting Person remains continuously employed on, or becomes retirement eligible prior to, such vesting date and has no expiration date. The restricted stock units vest in 16 equal quarterly installments, beginning on July 1, 2024, provided the Reporting Person remains continuously employed on, or becomes retirement eligible prior to, such vesting date and has no expiration date. The restricted stock units vest in 12 equal quarterly installments, beginning on July 1, 2025, provided the Reporting Person remains continuously employed on, or becomes retirement eligible prior to, such vesting date and has no expiration date.